Table 2

Main APIP adoption Effects

Effect of APIP adoption on main outcomes (before/after comparison). Sample: APIP schools and future APIP-schools
log of AP course enrollmentN
123456Placebo treatment
Treat0.162
[0.063]**
0.082
[0.069]
0.058
[0.075]
0.0951
[0.0732]
0.078
[0.072]
0.038
[0.067]
0.038
[0.067]
318
Percent 11 and 12 graders taking AB/IB exams
789101112Placebo treatment
Treat5.638
[0.919]**
2.557
[1.051]*
2.382
[0.874]*
2.2206
[0.676]*
2.233
[0.878]*
2.198
[0.893]*
−0.298
[1.211]
222
log of graduates
131415161718Placebo treatment
Treat0.227
[0.030]**
0.106
[0.036]**
0.0117
[0.0184]
0.0118
[0.0184]
0.009
[0.017]
0.005
[0.023]
−0.022
[0.021]
578
log of SAT/ACT takers
192021222324Placebo treatment
Treat0.189
[0.037]**
0.063
[0.046]
−0.0435
[0.0408]
−0.0464
[0.0541]
−0.046
[0.054]
−0.045
[0.045]
−0.049
[0.030]
578
log score above 1100/24 on SAT/ACT
252627282930Placebo treatment
Treat0.167
[0.058]**
0.232
[0.070]**
0.1361
[0.0527]*
0.1976
[0.0253]**
0.198
[0.025]**
0.199
[0.046]**
0.09
[0.084]
578
log attend college
313233343536Placebo treatment
Treat0.126
[0.035]**
0.117
[0.041]**
0.0496
[0.0283]*
0.0534
[0.0294]*
0.062
[0.030]*
0.048
[0.041]
−0.085
[0.057]
226
School fixed effectsYESYESYESYESYESYESYES
Year fixed effectsNOYESYESYESYESYESYES
Controls includedNONO122*2**1
Decile-by-year effectsNONONOYESYESYESYES
  • Robust standard errors in brackets. Standard error clustered at the district level.

  • + significant at 10 percent;

  • * significant at 5 percent; ** significant at 1 percent. All regressions are based on a panel of 57 schools. Each coefficient estimate is the result of a different regression. Each column represents the same specification, while each row indicates a different dependent variable. Demographic controls are log school enrollment, percent white, percent black, percent Hispanic, percent Asian, percent Native American, percent free lunch, percent LEP, and the log of mobile students. Specification 1 includes school controls and affected cohort size (Grade 12, Grade 11, lagged Grade 11 and lagged Grade 10 enrollment for AP outcomes, and Grade 12 and lagged Grade 11 enrollment for non-AP outcomes based on the cohort of high school graduates). Specification 2 includes all variables in Specification 1 and year-by-propensity score decile fixed effects (the preferred model). Specification 2* includes all variables in Specification 2 with the exception of 11th and Grade 12 enrollment for AP outcomes and omit Grade 12 enrollment for the non-AP outcomes based on the cohort of high school graduates. Specification 2** includes all variables in Specification 2 but excludes all grade enrollment variables. Placebo treatment uses the second lead of actual adoption as the treatment. This variable denotes two years before actual APIP adoption.